6 of the 18 tracked hedge funds hold BBIO (BRIDGEBIO PHARMA INC) in their latest 13F filing. Combined position: $1.19B.
| Fund | Shares | Position | This quarter |
|---|---|---|---|
| Andreas Halvorsen (Viking Global) | 9.95M | $741.0M | reduced |
| Ken Griffin (Citadel) | 4.72M | $351.7M | added |
| Jim Simons (Renaissance) | 856.8K | $63.8M | added |
| Ray Dalio (Bridgewater) | 448.1K | $33.4M | added |
| Ken Griffin (Citadel) | 13.1K | $976K | added |
| Ken Griffin (Citadel) | 10.0K | $745K | added |
Sold out, added to, or brand-new position — email you within minutes of the 13F filing.
← all whales · ← biggest moves this quarter
Data from SEC EDGAR quarterly 13F-HR filings. 13F filings are due 45 days after quarter end and reflect equity positions only (no shorts, no options, no non-US listings). By law they lag reality by up to 6 weeks — treat as historical, not real-time.